Sep 13, 2023 / 12:30PM GMT
Eric White Coldwell - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Good morning, everyone. My name is Eric Coldwell, pharma services and business distribution analyst at Baird. It's a real pleasure to have Cardinal with us today and some newer faces over the last few months, few years. Matt here, Matt Sims, new lead in IR. So that's fantastic.
Matt Sims -
Always been with the team for a little while so should known by most of you.
Eric White Coldwell - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Been with you for a while but recent news. I'm not going to do a big introduction. I want to jump into Q&A, but Matt, I know you wanted to make some opening comments just to get us roilling.
Matt Sims -
Yes. Just some quick housekeeping. So thanks, Eric, and thanks for hosting us here today. So during the fireside chat, we will be making forward-looking statements. Our actual results could differ materially from those
Cardinal Health Inc at Robert W Baird Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot